Advanced Search
LIU Yong. Advances in Clinical Application of ctDNA in Tumor Detection, Screening, Prognosis and Treatment[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 627-631. DOI: 10.3971/j.issn.1000-8578.2020.19.1444
Citation: LIU Yong. Advances in Clinical Application of ctDNA in Tumor Detection, Screening, Prognosis and Treatment[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 627-631. DOI: 10.3971/j.issn.1000-8578.2020.19.1444

Advances in Clinical Application of ctDNA in Tumor Detection, Screening, Prognosis and Treatment

  • Circulating tumor DNA (ctDNA) is a tumor-derived fragmented DNA in blood and is a characteristic marker of tumor. Through the correlative detection of ctDNA, the trace information of the tumor in the blood of the patients can be detected, and the panoramic data of the tumor can be provided. As a non-invasive detection method, ctDNA plays an important role in the screening, prognosis and treatment of tumors. This article will describe the origin of ctDNA, the detection technology of ctDNA, the potential application of ctDNA in tumor detection and treatment, and the related problems faced by ctDNA detection technology.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return